Group One Trading
IMNM icon

Group One Trading’s Immunome IMNM Stock Holding History

Group One Trading’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1K Sell
2,200
-7,300
-77% -$162K ﹤0.01% 5286
2025
Q4 		$204K Buy
9,500
+6,500
+217% +$114K ﹤0.01% 4352
2025
Q3 		$35.1K Sell
3,000
-1,800
-38% -$17.9K ﹤0.01% 6240
2025
Q2 		$44.6K Buy
4,800
+2,300
+92% +$18.9K ﹤0.01% 5673
2025
Q1 		$16.8K Buy
2,500
+800
+47% +$7.67K ﹤0.01% 5934
2024
Q4 		$18.1K Sell
1,700
-13,400
-89% -$162K ﹤0.01% 5762
2024
Q3 		$221K Buy
15,100
+14,900
+7,450% +$212K ﹤0.01% 3521
2024
Q2 		$2.42K Buy
+200
New +$3.13K ﹤0.01% 6168
2023
Q3 		– Sell
-100
Closed -$791 – 7933
2023
Q2 		$791 Buy
+100
New +$547 ﹤0.01% 7308
2021
Q4 		– Sell
-100
Closed -$2K – 8485
2021
Q3 		$2K Buy
+100
New +$1.74K ﹤0.01% 7937

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Group One Trading's IMNM Position: Q1 2026 in Review

Group One Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 22,999 shares — an estimated $512K sold.

Group One Trading first reported a position in IMNM in Q2 2022 and held it in 10 quarters. The position peaked at $494K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Group One Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 22,999 Immunome shares in Q1 2026, an estimated $512K.
  • Group One Trading first reported a position in Immunome in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Immunome position peaked at $494K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.